Get in touch

Get in touch

Your enquiry will be sent to the relevant lead trial centre or sponsor. We need either an email address or phone number to enable the trial team to respond to your query.  Any form submitted without either of these cannot be processed.

A Phase 3b, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-445/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects, Homozygous for F508del (VX18-445-109)

Name
Nature of enquiry
I am

Information entered into this contact form will not be stored by the Cystic Fibrosis Trust

Your enquiry will be sent to the relevant lead trial centre or Sponsor

Your donation will make a difference:

Select amount
Select amount